| __timestamp | Lantheus Holdings, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 1802274 |
| Thursday, January 1, 2015 | 78634000 | 2512761 |
| Friday, January 1, 2016 | 75374000 | 2894488 |
| Sunday, January 1, 2017 | 92157000 | 8096274 |
| Monday, January 1, 2018 | 93326000 | 7985229 |
| Tuesday, January 1, 2019 | 103132000 | 8994597 |
| Wednesday, January 1, 2020 | 110171000 | 29772000 |
| Friday, January 1, 2021 | 218817000 | 33907000 |
| Saturday, January 1, 2022 | 233827000 | 26579000 |
| Sunday, January 1, 2023 | 267194000 | 49868547 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. Lantheus Holdings, Inc. and Verona Pharma plc, two prominent companies, have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, Lantheus Holdings, Inc. experienced a significant increase in SG&A expenses, growing by approximately 270%, from $72 million to $267 million. This upward trajectory reflects their aggressive expansion and investment in administrative capabilities. In contrast, Verona Pharma plc's SG&A expenses, while also increasing, grew at a more modest pace, rising from $1.8 million to nearly $50 million, marking a 27-fold increase.
These trends highlight the differing strategic priorities of the two companies, with Lantheus focusing on scaling operations and Verona Pharma emphasizing targeted growth.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Verona Pharma plc
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Verona Pharma plc and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Verona Pharma plc vs MiMedx Group, Inc. Trends and Insights